O A Baturina1, D A Andreev, N A Ananicheva
1Sechenov First Moscow State Medical University (Sechenov University). o.a.baturina@yandex.ru.
Atrial fibrillation (AF) is common in acute coronary syndrome (ACS) patients. Most eligible AF patients received oral anticoagulants, with novel oral anticoagulants (NOACs) preferred over vitamin K antagonists.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: